Mental Health Treatment: Compass Pathways And Greenbrook TMS Join Forces For Psilocybin Therapy Research
Exploring Psilocybin Therapy: Research Collaboration Between Compass Pathways And Greenbrook TMS
Research Collaboration Biotechnology company Compass Pathways plc (CMPS) and Greenbrook TMS Inc (GBNH) have struck a three-year research collaboration agreement to study delivery models for investigational COMP360 psilocybin treatment. Scope of the Partnership The collaboration aims to research and investigate models for the delivery of scalable, commercial COMP360 within healthcare systems, assuming FDA approval. Initial ...